Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

CSIR Recruitment 2020 For Biological Sciences at TKDL Unit – Apply Online

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes
  • BiotechToday
  • World

CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

bioxone October 11, 2020October 10, 2020

-Surupa Chakraborty, Amity University Kolkata

A new CRISPR based test that can diagnose the coronavirus infection within few minutes, joins the race of speedy detection after RT-PCR, rapid testing, and FELUDA test. The potent applications of CRISPR have been talked about for many years now. It is best known for its ability to seek out and cut genetic material with unparalleled accuracy. Using this property, the researchers programmed CRISPR to search for specific genetic sequences found only in the SARS-CoV-2 virus.

The study published in the Science journal says that it is an inexpensive diagnostic test that could potentially detect the trace of the viral infection within 5 minutes using minimal lab equipment. Previously developed CRISPR based tests by the team, worked by identifying a 20 base long RNA sequence unique to SARS-CoV-2. The scientists created a ‘guide’ RNA complementary to the target RNA sequence which can bind together in the test solution. This in turn activates the CRISPR/Cas 13 ‘molecular scissors’ which cuts apart any single-stranded RNAs present nearby. These cuts generate fluorescent particles in the solution which emit fluorescent signals when hit by a laser beam. But this required the researchers to first amplify the viral RNA present in the sample, to increase the chances of spotting the signal, thereby, adding to its complexity, time, and cost of the diagnosis.

However, the recently developed novel CRISPR-based diagnostic test is based on multiple guide RNAs that work in unison to increase the sensitivity of the test, without the need of amplifying the viral RNA. The test was developed by a team of researchers, led by Jennifer Doudna, a recipient of the Nobel Prize in Chemistry, 2020, for her co-discovery of CRISPR. The test detected as few as 100,000 viruses per microliter of the solution with a single guide RNA, and 100 viruses per microliter with an additional guide RNA. Among samples taken from Covid-19 patients, it was able to precisely identify a batch of five positive samples within 5 minutes per test.

Also, this test is rendered beneficial in quantifying the viral load in the patients, which can help the doctors in their treatment procedures. A mobile phone-based device can be used to directly interpret the results of the diagnosis, which makes the entire assay portable, compared to bulky lab-based plate readers. Combined with efficient contact tracing, this CRISPR based SARS-CoV-2 easy detection test can thus play a pivotal role in the control of the current pandemic.

Source:

Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone. Parinaz Fozouni, Katherine S. Pollard, Joseph L. DeRisi, Jennifer A. Doudna, Daniel A. Melanie Ott, et al., (2020), medRxiv, https://doi.org/10.1101/2020.09.28.20201947

Also read: Soil Microbes Consume Atmospheric Hydrogen

For more articles, visit bioxone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged clinical trials COVID-19 CRISPR/Cas13a crRNAs direct detection assay pandemic quantification rapid testing SARS-CoV-2 screening

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India
  • World

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

bioxone October 11, 2020

-Richismita Hazra, Amity University Kolkata Antibodies serve as analytical barriers to viruses or viral infections. They play a dual role in communicating the existence of invading pathogens in infected cells, also, in interfering with the processes that are essential to the viral lifecycle. The antibodies activate phagocytes which is a potential mechanism of eradiating viruses. […]

Related Post

  • BiotechToday
  • World

Has evolution made childbirth easier or not?

bioxone April 30, 2021April 29, 2021

Anannya Roy, Amity University Kolkata It is said that labour pain equals pain felt when 20 bones crack at the same time. Ouch. Just thinking about it is painful. A woman indeed is a strong and marvellous creation of God who is bestowed with the gift of creating Life. This gift comes with a price, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Threats to T-cell over-activation in response to CD28

bioxone November 28, 2020November 28, 2020

PRAGYA SANTRA, AMITY UNIVERSITY Genome-wide association studies (GWAS) mapped the T-cell stimulatory pathways along with the CD28, CTLA4, and ICOS genes. GWAS studies and autoimmune disorders identified enriched chromatin regions as a consequence of memory T-cell over-activation. T-cell stimulation after occurring in the secondary lymphoid delivers two signals, first via T-cell receptors (TCR) to recognize […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

Bacterial hydrogen sulphide biogenesis contributes to antibiotic resistance

bioxone June 14, 2021June 16, 2021

 Souradip Mallick, National Institute of Technology, Rourkela Growing antimicrobial resistance is one of the major threats to the world.  It has been estimated that over 10 million deaths each year by 2050 if no action is taken. The World Health Organization (WHO) also apprises that by 2030, drug-resistant diseases could force up to 24 million […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy